APA (7th ed.) Citation

TJ, S., GR, B., E, M., MC, H., M, D., E, E., . . . Gitton, X. (2004). Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: Randomised controlled trial. Lancet, 364(9435), 665. https://doi.org/10.1016/s0140-6736(04)16893-1

Chicago Style (17th ed.) Citation

TJ, Schnitzer, et al. "Comparison of Lumiracoxib with Naproxen and Ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), Reduction in Ulcer Complications: Randomised Controlled Trial." Lancet 364, no. 9435 (2004): 665. https://doi.org/10.1016/s0140-6736(04)16893-1.

MLA (9th ed.) Citation

TJ, Schnitzer, et al. "Comparison of Lumiracoxib with Naproxen and Ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), Reduction in Ulcer Complications: Randomised Controlled Trial." Lancet, vol. 364, no. 9435, 2004, p. 665, https://doi.org/10.1016/s0140-6736(04)16893-1.